Literature DB >> 19262557

A sesquiterpene quinone, dysidine, from the sponge Dysidea villosa, activates the insulin pathway through inhibition of PTPases.

Yu Zhang1, Yan Li, Yue-wei Guo, Hua-liang Jiang, Xu Shen.   

Abstract

AIM: The sesquiterpene hydroquinones/quinones belong to one class of marine sponge metabolites, and they have received considerable attention due to their varied biological activities, including anti-tumor, anti-HIV, and anti-inflammatory action. In order to probe the potential anti-diabetic effect of the sesquiterpene hydroquinones/quinones, the effect of dysidine on the insulin pathway was studied.
METHODS: The promotion of glucose uptake by dysidine was studied in differentiated 3T3-L1 cells. The increase in membrane-located GLUT4 by dysidine was studied in CHO-K1/GLUT4 and 3T3-L1 cells by immuno-staining. The activation of the insulin signaling pathway by dysidine was probed by Western blotting. The inhibition of PTPases by dysidine was detected in vitro.
RESULTS: Dysidine, found in the Hainan sponge Dysidea villosa in the Chinese South Sea, effectively activated the insulin signaling pathway, greatly promoted glucose uptake in 3T3-L1 cells, and showed strong insulin-sensitizing activities. The potential targets of action for dysidine were probed, and the results indicated that dysidine exhibited its cellular effects through activation of the insulin pathway, possibly through the inhibition of protein tyrosine phosphatases, with more specific inhibition against protein tyrosine phosphatase 1B (PTP1B).
CONCLUSION: Our findings are expected to expand understanding of the biological activities of sesquiterpene hydroquinones/quinones, and they show that dysidine could be a potential lead compound in the development of an alternative adjuvant in insulin therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262557      PMCID: PMC4002405          DOI: 10.1038/aps.2009.5

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  44 in total

Review 1.  Drugs from the seas - current status and microbiological implications.

Authors:  P Proksch; R A Edrada; R Ebel
Journal:  Appl Microbiol Biotechnol       Date:  2002-06-12       Impact factor: 4.813

2.  Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells: regulation by amino acid concentrations.

Authors:  J S Bogan; A E McKee; H F Lodish
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte functions.

Authors:  C Giannini; C Debitus; R Lucas; A Ubeda; M Payá; J N Hooper; M V D'Auria
Journal:  J Nat Prod       Date:  2001-05       Impact factor: 4.050

5.  Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.

Authors:  B J Goldstein; A Bittner-Kowalczyk; M F White; M Harbeck
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

6.  Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma.

Authors:  C Nugent; J B Prins; J P Whitehead; J M Wentworth; V K Chatterjee; S O'Rahilly
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

7.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

Authors:  Alan Cheng; Noriko Uetani; Paul D Simoncic; Vikas P Chaubey; Ailsa Lee-Loy; C Jane McGlade; Brian P Kennedy; Michel L Tremblay
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

8.  PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.

Authors:  Bradley A Zinker; Cristina M Rondinone; James M Trevillyan; Rebecca J Gum; Jill E Clampit; Jeffrey F Waring; Nancy Xie; Denise Wilcox; Peer Jacobson; Leigh Frost; Paul E Kroeger; Regina M Reilly; Sandra Koterski; Terry J Opgenorth; Roger G Ulrich; Seth Crosby; Madeline Butler; Susan F Murray; Robert A McKay; Sanjay Bhanot; Brett P Monia; Michael R Jirousek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

9.  Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases.

Authors:  Hua Fu; Junguk Park; Dehua Pei
Journal:  Biochemistry       Date:  2002-08-27       Impact factor: 3.162

10.  Demonstration of insulin-responsive trafficking of GLUT4 and vpTR in fibroblasts.

Authors:  M A Lampson; A Racz; S W Cushman; T E McGraw
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  9 in total

Review 1.  Bioactive natural products from Chinese marine flora and fauna.

Authors:  Zhen-Fang Zhou; Yue-Wei Guo
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

2.  Discovery of novel PTP1B inhibitors with antihyperglycemic activity.

Authors:  Zhang Liu; Qian Chai; Yuan-yuan Li; Qiang Shen; Lan-ping Ma; Li-na Zhang; Xin Wang; Li Sheng; Jing-ya Li; Jia Li; Jing-kang Shen
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

3.  Chronic ethanol consumption up-regulates protein-tyrosine phosphatase-1B (PTP1B) expression in rat skeletal muscle.

Authors:  Li GAO; Xu ZHANG; Fu-rong WANG; Ming-feng CAO; Xiu-juan ZHANG; Nan-nan SUN; Jie ZHANG; Ling GAO; Jia-jun ZHAO
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

Review 4.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

Review 5.  Marine Organisms with Anti-Diabetes Properties.

Authors:  Chiara Lauritano; Adrianna Ianora
Journal:  Mar Drugs       Date:  2016-12-01       Impact factor: 5.118

Review 6.  Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.

Authors:  Palma Lamonaca; Giulia Prinzi; Aliaksei Kisialiou; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2017-03-20       Impact factor: 5.118

7.  Elucidating Drug-Like Compounds and Potential Mechanisms of Corn Silk (Stigma Maydis) against Obesity: A Network Pharmacology Study.

Authors:  Ki-Kwang Oh; Md Adnan; Dong-Ha Cho
Journal:  Curr Issues Mol Biol       Date:  2021-11-06       Impact factor: 2.976

8.  Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity.

Authors:  Laura Guasch; Esther Sala; Miquel Mulero; Cristina Valls; Maria Josepa Salvadó; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Meroterpenes from marine invertebrates: structures, occurrence, and ecological implications.

Authors:  Marialuisa Menna; Concetta Imperatore; Filomena D'Aniello; Anna Aiello
Journal:  Mar Drugs       Date:  2013-05-17       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.